Transdermal skin patches are medication-dispensing adhesive patches intended to deliver a specific dose of medication through the skin and into the bloodstream. They are used for the controlled delivery of drugs through the skin at a predetermined rate and are often used for the treatment of chronic pain, hormonal therapies and smoking cessation aids. Skin patches offer advantages like self-administration of drugs, flexibility of use, avoidance of first-pass hepatic metabolism and sustained drug delivery. The need for alternative non-invasive methods of drug delivery has increased the demand for transdermal skin patches recently.
Market Opportunity:
Pain management using transdermal skin patches offers an immense growth opportunity for the market. Chronic pain affects nearly 50 million Americans annually and is rising globally owing to aging population and changing disease patterns. Skin patches provide a non-invasive alternative to oral pills for pain management and ensure steadying drug levels for around 3 days compared to oral medications. Their convenience of use and ability to offer sustained drug release for pain management has increased acceptance among chronic pain patients. This represents a lucrative opportunity for transdermal skin patches manufacturers to develop effective pain management patches.
Porter's Analysis
Threat of new entrants: Low cost of manufacturing and developing transdermal skin patches makes it easy for new players to enter the market. However, high R&D costs and stringent regulations make entry difficult.
Bargaining power of buyers: Large buyers have significant bargaining power due to availability of alternative treatment options and ability to demand lower prices. However, specialized nature of patches limits impact of bargaining power.
Bargaining power of suppliers: Few suppliers of raw materials needed for patches production puts them in advantageous position. However, availability of substitutes mitigates their bargaining power.
Threat of new substitutes: Alternatives like oral drugs and injectables pose threat, though patches provide convenient non-invasive delivery.
Competitive rivalry: Intense competition due to large number of players with similar offerings leads to pricing pressures and incentives for innovation.
SWOT Analysis
Strength: Non-invasive delivery ensures patient comfort and compliance. Ability to deliver drugs continuously for extended periods.
Weakness: Limited drug types that can be delivered. Storage and distribution challenges due to temperature and humidity controls needed.
Opportunity: Growing demand for alternative delivery modes and self-administered treatments increases market potential. Untapped regions especially in developing world offer scope.
Threats: Stringent regulations delay product approvals and increase costs. Reimbursement and pricing issues pose challenges in implementation.
Key Takeaways
The Global Transdermal Skin Patches Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: Asia Pacific comprises the region holding immense potential for transdermal patches market growth. Factors like rising incomes, expanding medical insurance coverage and growing preference for convenient delivery options are supporting market expansion. China accounts for a major share attributed to large population and healthcare reforms. India is also emerging as a high growth country market.
Key players operating in the transdermal skin patches market are Omsk Carbon Group, Tokai Carbon Co., Ltd., Atlas Organics Private Limited, Continental Carbon Company, Birla Carbon, Cabot Corporation, International China Oak Investment Holdings Co., Ltd., Himadri Speciality Chemical Ltd, Philips Carbon Black Limited, Orion Engineered Carbons GmbH, Ralson. Key players are focused on product innovations to leverage new opportunities.
Explore more information on this topic, Please visit -
https://www.ukwebwire.com/transdermal-skin-patches-market-growth-and-forecasts-analysis/
Explore more trending article related this topic -
Comments
0 comment